These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Molecular and biochemical basis for variants and deficiency forms of galactose-1-phosphate uridyltransferase. Shin YS; Zschocke J; Das AM; Podskarbi T J Inherit Metab Dis; 1999 May; 22(3):327-9. PubMed ID: 10384398 [No Abstract] [Full Text] [Related]
44. The natural history of classic galactosemia: lessons from the GalNet registry. Rubio-Gozalbo ME; Haskovic M; Bosch AM; Burnyte B; Coelho AI; Cassiman D; Couce ML; Dawson C; Demirbas D; Derks T; Eyskens F; Forga MT; Grunewald S; Häberle J; Hochuli M; Hubert A; Huidekoper HH; Janeiro P; Kotzka J; Knerr I; Labrune P; Landau YE; Langendonk JG; Möslinger D; Müller-Wieland D; Murphy E; Õunap K; Ramadza D; Rivera IA; Scholl-Buergi S; Stepien KM; Thijs A; Tran C; Vara R; Visser G; Vos R; de Vries M; Waisbren SE; Welsink-Karssies MM; Wortmann SB; Gautschi M; Treacy EP; Berry GT Orphanet J Rare Dis; 2019 Apr; 14(1):86. PubMed ID: 31029175 [TBL] [Abstract][Full Text] [Related]
45. Prevention of a molecular misdiagnosis in galactosemia. Barbouth D; Slepak T; Klapper H; Lai K; Elsas LJ Genet Med; 2006 Mar; 8(3):178-82. PubMed ID: 16540753 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of reduced activity galactose-1-phosphate uridyl transferase by combined radioisotopic assay and high-resolution isoelectric focusing. Kelley RI; Segal S J Lab Clin Med; 1989 Aug; 114(2):152-6. PubMed ID: 2546999 [TBL] [Abstract][Full Text] [Related]
47. Analysis of the Structure-Function-Dynamics Relationships of GALT Enzyme and of Its Pathogenic Mutant p.Q188R: A Molecular Dynamics Simulation Study in Different Experimental Conditions. Verdino A; D'Urso G; Tammone C; Scafuri B; Marabotti A Molecules; 2021 Sep; 26(19):. PubMed ID: 34641485 [TBL] [Abstract][Full Text] [Related]
48. Molecular and biochemical basis of galactosemia. Wang BB; Xu YK; Ng WG; Wong LJ Mol Genet Metab; 1998 Apr; 63(4):263-9. PubMed ID: 9635294 [TBL] [Abstract][Full Text] [Related]
49. Galactose-1-phosphate inhibits cytochrome c oxidase and causes mitochondrial dysfunction in classic galactosemia. Machado CM; de-Souza-Ferreira E; Silva GFS; Pimentel FSA; De-Souza EA; Silva-Rodrigues T; Gandara ACP; Zeidler JD; Fernandes-Siqueira LO; De-Queiroz ALFV; Andrade-Silva L; Victória-Martins K; Fernandes-Carvalho C; Chini EN; Passos JF; Da Poian AT; Montero-Lomelí M; Galina A; Masuda CA Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167340. PubMed ID: 38986816 [TBL] [Abstract][Full Text] [Related]
50. Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular models. Haskovic M; Coelho AI; Bierau J; Vanoevelen JM; Steinbusch LKM; Zimmermann LJI; Villamor-Martinez E; Berry GT; Rubio-Gozalbo ME J Inherit Metab Dis; 2020 May; 43(3):392-408. PubMed ID: 31808946 [TBL] [Abstract][Full Text] [Related]
51. Of mice and men: galactosemia. Segal S Mol Genet Metab; 2006 Dec; 89(4):401-2. PubMed ID: 16914342 [No Abstract] [Full Text] [Related]
52. A yeast expression system for human galactose-1-phosphate uridylyltransferase. Fridovich-Keil JL; Jinks-Robertson S Proc Natl Acad Sci U S A; 1993 Jan; 90(2):398-402. PubMed ID: 8421669 [TBL] [Abstract][Full Text] [Related]